UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Health-Related Quality-of-Life Parameters as Independent Prognostic Factors in Advanced or Metastatic Bladder Cancer

Journal of clinical oncology, 2003-02, Vol.21 (4), p.673-678

2003

Volltextzugriff (PDF)

A comprehensive review of nongenetic prognostic and predictive factors influencing the heterogeneity of outcomes in advanced non-small-cell lung cancer

Cancer management and research, 2014-01, Vol.6 (default), p.437-449

2014

Volltextzugriff (PDF)

PCN1 - Adding Ramucirumab To Second-Line Irinotecan, 5-Fluorouracil and Folinic Acid (Folfiri) Treatment for Metastatic Colorectal Carcinoma (Mcrc): Resource Utilization Data from Raise, A Global, Randomized, Double-Blind, Multicenter Phase 3 Study

Value in health, 2017-10, Vol.20 (9), p.A871-A871

2017

Volltextzugriff (PDF)

Adding Ramucirumab To Second-Line Irinotecan, 5-Fluorouracil and Folinic Acid (Folfiri) Treatment for Metastatic Colorectal Carcinoma (Mcrc): Resource Utilization Data from Raise, A Global, Randomized, Double-Blind, Multicenter Phase 3 Study

Value in health, 2017-10, Vol.20 (9), p.A871

2017

Volltextzugriff (PDF)

HEALTH CARE RESOURCE USE AMONG ADVANCED GASTRIC CANCER PATIENTS IN TAIWAN AND SOUTH KOREA

Value in health, 2014-11, Vol.17 (7), p.A734-A734

2014

Volltextzugriff (PDF)

Adapting the Lung Cancer Symptom Scale (LCSS) to mesothelioma

Cancer, 2004-08, Vol.101 (3), p.587-595

2004

Volltextzugriff (PDF)

Phase II Study of Pemetrexed-Gemcitabine Combination in Patients with Advanced-Stage Non-Small Cell Lung Cancer

Clinical cancer research, 2004-08, Vol.10 (16), p.5439-5446

2004

Volltextzugriff (PDF)

PCN7 - HEALTH CARE RESOURCE USE AMONG ADVANCED GASTRIC CANCER PATIENTS IN TAIWAN AND SOUTH KOREA

Value in health, 2014-11, Vol.17 (7), p.A734-A734

2014

Volltextzugriff (PDF)

Measuring quality of life in patients with pleural mesothelioma using a modified version of the Lung Cancer Symptom Scale (LCSS): psychometric properties of the LCSS-Meso

Supportive care in cancer, 2006-01, Vol.14 (1), p.11-21

2006

Volltextzugriff (PDF)

PCN84 VALIDATION OF THE EUROQOL EQ-5D IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA (RR MCL)

Value in health, 2009, Vol.12 (3), p.A52-A52

2009

Volltextzugriff (PDF)

PCN25 THE BUDGETARY IMPACT OF PEMETREXED MAINTENANCE THERAPY FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER

Value in health, 2010, Vol.13 (3), p.A28-A28

2010

Volltextzugriff (PDF)

PCN20 THE BUDGETARY IMPACT OF PEMETREXED PLUS CISPLATIN AS FIRST-LINE THERAPY FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)

Value in health, 2009, Vol.12 (3), p.A39-A39

2009

Volltextzugriff (PDF)

PCN59 TREATMENT PATTERNS FOR PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM) IN GERMANY

Value in health, 2007, Vol.10 (6), p.A340-A341

2007

Volltextzugriff (PDF)

PCN10 COST-EFFECTIVENESS OF GEMCITABINE-PACLITAXEL COMBINATION IN THE TREATMENT OF ADVANCED BREAST CANCER AFTER FAILURE OF ANTHRACYCLINE THERAPY

Value in health, 2006-05, Vol.9 (3), p.A106-A107

2006

Volltextzugriff (PDF)

PCN41 EQ-5D IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): ASSESSMENT OF VALIDITY AND RESPONSIVENESS

Value in health, 2006-05, Vol.9 (3), p.A116-A116

2006

Volltextzugriff (PDF)

PCN30 IMPROVED TOXICITY PROFILE OF PEMETREXEDVS DOCETAXEL IN PREVIOUSLY TREATED NON-SMALL CELL LUNG CANCER PATIENTS TRANSLATES TO COST SAVINGS IN SPAIN

Value in health, 2004-11, Vol.7 (6), p.678-679

2004

Volltextzugriff (PDF)

PCN10 COSTS OF MANAGING TOXICITIES IN ADVANCED NON-SMALL CELL LUNG CANCER WITH PEMETREXED COMPARED WITH DOCETAXEL AS SECOND-LINE CHEMOTHERAPY

Value in health, 2003-11, Vol.6 (6), p.734-735

2003

Volltextzugriff (PDF)

PCN3I EVALUATION OF PEMETREXED VERSUS DOCETAXEL IN THE SECOND-LINE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER: PATIENT PREFERENCE AND WILLINGNESS-TO-PAYWITH DISCRETE CHOICE CONJOINT ANALYSIS

Value in health, 2004-11, Vol.7 (6), p.679-679

2004

Volltextzugriff (PDF)

Review of the pharmacoeconomic research on gemcitabine in the treatment of advanced non-small cell lung cancer

The American journal of managed care, 1998-11, Vol.4 (11), p.1591

1998

Volltextzugriff (PDF)

PP48. A review of the pharmacoeconomic research on Gemcitabine (Gemzar TM) in the treatment of advanced non-small cell lung cancer

European journal of cancer (1990), 1997-11, Vol.33, p.S32-S32

1997

Volltextzugriff (PDF)

OP19. Quality of life assessments of patients with pancreatic cancer receiving MTA (LY231514, a multi-targeted antifolate)

European journal of cancer (1990), 1997-11, Vol.33, p.S8-S8

1997

Volltextzugriff (PDF)

PP43. Quality of life assessments of patients with non-small cell lung cancer receiving gemcitabine (Gemzar ™) and cisplatin

European journal of cancer (1990), 1997-11, Vol.33, p.S30-S30

1997

Volltextzugriff (PDF)

A Retrospective Observational Study of the Epidemiology of Advanced Gastric Cancer in Germany

Gesundheitsökonomie & Qualitätsmanagement, 2014-09, Vol.20 (3), p.108-113

2014

Volltextzugriff (PDF)

PINUS SYLVESTRIS L. NATURAL REGENERATION AFTER GRADUAL CONTINUOUS FELLING IN VACCINIOSA, MYRTILLOSA AND HYLOCOMIOSA

Proceedings of the International Scientific Conference: Rural Development, 2022-01, Vol.2021 (1), p.201-206

2022

Volltextzugriff (PDF)

ChemInform Abstract: TUMOR‐INHIBITOREN 87. MITT. TOTALSYNTH. DES TUMORHEMMENDEN ALKALOIDS THALICARPIN

Chemischer Informationsdienst, 1973-07, Vol.4 (27)

1973

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(25)

Sprache

Englisch
(24)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(6)
Oncology
(6)
Science & Technology
(6)
Internal Medicine
(5)
Humans
(4)
Female
(3)
Male
(3)
Middle Aged
(3)
Quality Of Life
(3)
Adult
(2)
Aged
(2)
Biological And Medical Sciences
(2)
Cancer Therapies
(2)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(2)
Deoxycytidine - Analogs & Derivatives
(2)
Health Care Sciences & Services
(2)
Lung Cancer
(2)
Lung Cancer Symptom Scale
(2)
Medical Sciences
(2)
Patients
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Health-Related Quality-of-Life Parameters as Independent Prognostic Factors in Advanced or Metastatic Bladder Cancer

A comprehensive review of nongenetic prognostic and predictive factors influencing the heterogeneity of outcomes in advanced non-small-cell lung cancer

PCN1 - Adding Ramucirumab To Second-Line Irinotecan, 5-Fluorouracil and Folinic Acid (Folfiri) Treatment for Metastatic Colorectal Carcinoma (Mcrc): Resource Utilization Data from Raise, A Global, Randomized, Double-Blind, Multicenter Phase 3 Study

Adding Ramucirumab To Second-Line Irinotecan, 5-Fluorouracil and Folinic Acid (Folfiri) Treatment for Metastatic Colorectal Carcinoma (Mcrc): Resource Utilization Data from Raise, A Global, Randomized, Double-Blind, Multicenter Phase 3 Study

HEALTH CARE RESOURCE USE AMONG ADVANCED GASTRIC CANCER PATIENTS IN TAIWAN AND SOUTH KOREA

Adapting the Lung Cancer Symptom Scale (LCSS) to mesothelioma

Phase II Study of Pemetrexed-Gemcitabine Combination in Patients with Advanced-Stage Non-Small Cell Lung Cancer

PCN7 - HEALTH CARE RESOURCE USE AMONG ADVANCED GASTRIC CANCER PATIENTS IN TAIWAN AND SOUTH KOREA

Measuring quality of life in patients with pleural mesothelioma using a modified version of the Lung Cancer Symptom Scale (LCSS): psychometric properties of the LCSS-Meso

PCN84 VALIDATION OF THE EUROQOL EQ-5D IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA (RR MCL)

PCN25 THE BUDGETARY IMPACT OF PEMETREXED MAINTENANCE THERAPY FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER

PCN20 THE BUDGETARY IMPACT OF PEMETREXED PLUS CISPLATIN AS FIRST-LINE THERAPY FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)

PCN59 TREATMENT PATTERNS FOR PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM) IN GERMANY

PCN10 COST-EFFECTIVENESS OF GEMCITABINE-PACLITAXEL COMBINATION IN THE TREATMENT OF ADVANCED BREAST CANCER AFTER FAILURE OF ANTHRACYCLINE THERAPY

PCN41 EQ-5D IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): ASSESSMENT OF VALIDITY AND RESPONSIVENESS

PCN30 IMPROVED TOXICITY PROFILE OF PEMETREXEDVS DOCETAXEL IN PREVIOUSLY TREATED NON-SMALL CELL LUNG CANCER PATIENTS TRANSLATES TO COST SAVINGS IN SPAIN

PCN10 COSTS OF MANAGING TOXICITIES IN ADVANCED NON-SMALL CELL LUNG CANCER WITH PEMETREXED COMPARED WITH DOCETAXEL AS SECOND-LINE CHEMOTHERAPY

PCN3I EVALUATION OF PEMETREXED VERSUS DOCETAXEL IN THE SECOND-LINE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER: PATIENT PREFERENCE AND WILLINGNESS-TO-PAYWITH DISCRETE CHOICE CONJOINT ANALYSIS

Review of the pharmacoeconomic research on gemcitabine in the treatment of advanced non-small cell lung cancer

PP48. A review of the pharmacoeconomic research on Gemcitabine (Gemzar TM) in the treatment of advanced non-small cell lung cancer

OP19. Quality of life assessments of patients with pancreatic cancer receiving MTA (LY231514, a multi-targeted antifolate)

PP43. Quality of life assessments of patients with non-small cell lung cancer receiving gemcitabine (Gemzar ™) and cisplatin

A Retrospective Observational Study of the Epidemiology of Advanced Gastric Cancer in Germany

PINUS SYLVESTRIS L. NATURAL REGENERATION AFTER GRADUAL CONTINUOUS FELLING IN VACCINIOSA, MYRTILLOSA AND HYLOCOMIOSA

ChemInform Abstract: TUMOR‐INHIBITOREN 87. MITT. TOTALSYNTH. DES TUMORHEMMENDEN ALKALOIDS THALICARPIN

Suchergebnisse filtern